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Introduction: The battery operated hand-held fan (“fan”) and the Calming Hand (CH), a 
cognitive strategy, are interventions used in clinial practice to relieve chronic breathlessness. 
Objective: To test the feasibility of a phase III randomised controlled trial (RCT) evaluating 
the impact of the fan and/or CH compared with exercis  advice alone for the relief of chronic 
breathlessness due to respiratory conditions.  
Methods: Single site, feasibility “2x2” factorial, non-blinde , mixed-methods RCT. 
Participants randomly allocated to four groups: fan + exercise advice vs CH + exercise advice 
vs fan + CH + exercise advice vs exercise advice alone. Measures included: recruitmen , 
acceptability; data quality and study outcomes (baseline, day 28); modified incremental 
shuttle walk test (mISWT), recovery time from exertion-induced breathlessness, Life-space, 
General Self-Efficacy Scale and breathlessness numerical rating scales. Willing participants 
and carers were interviewed at study end. 
Results: Recruitment/acceptability/data completion: 53 peopl  were screened, 40 randomised 
and completed; (mean age 72 years (SD 9.8), 70% male). Th re were few missing data (2 
mISWT). Recovery time [seconds] from exertion-induced breathlessness showed most 
improvement for the fan; mean reduction from baseline -33.5 vs CH mean increase from 
baseline 5.7. This represents a recovery speed at day 28 -20.4% faster for the fan vs 4.1% 
slower for the CH. 
Qualitative data indicated participants valued the faster recovery and identified the fan as a 
useful “medical” device, but found the CH unhelpful.  
Conclusion: A phase III RCT is feasible. Mixed-method data synthesis supports recovery 

















People with progressive cardiorespiratory conditions frequently experience disabling chronic 
breathlessness that seriously affects daily life despit  optimum treatment of their underlying 
disease (1). It is associated with poor health outcomes; reduced quality of life,(2) restricted 
activities,(3) emergency healthcare and hospital admissions.(4) Despite the widespread 
effects of breathlessness chronic breathlessness is often invisible to the clinician and therefore 
overlooked, leaving patients, carers and family memb rs to manage the symptom burden with 
little professional help.(5)   
Management is modelled on a multi-disciplinary, complex intervention that incorporates a 
range of pharmacological and non-pharmacological interventions.(6) Non-pharmacological 
interventions promote self-efficacy, with some patien s becoming expert in self-
management.(7) A clinical framework of “Breathing”, “Thinking” and “Functioning”, can be 
used to target interventions which address vicious circles (ineffective ventilation, anxiety, 
reduced physical activity) that perpetuate the effects of breathlessness.(8)  
Worse breathlessness is most commonly induced by physical exertion.(9) Frequent episodes 
restrict normal daily activities, particularly if the patient and/or family carer perceives 
breathlessness as an unpleasant or harmful experienc  to be avoided. A deconditioning spiral 
is thus perpetuated as lack of activity weakens periph al muscles until breathlessness is 
eventually precipitated from the slightest physical effort.  
Therefore, interventions which target exertion-induced breathlessness may improve the 
patient’s experience of everyday activities and prevent exercise avoidance. Strong evidence 
supports the role of exercise and activity to reduc the impact of breathlessness,(10) yet the 
patients misperception of the symptom as inherently dangerous may act as a disincentive to 
continue activities and reduce adherence to a rehabilitation programme.(11, 12)  However, 
the strength of evidence varies for non-pharmacological interventions, and is sparse for some, 
an issue highlighted by previous Cochrane review (update in preparation).(13)  
Two interventions used in clinical practice are the battery operated hand-held fan (“fan”) and 
the Calming Hand (CH) (a cognitive strategy [Online supplementary diagram]). (14) 















breathlessness.(15) Stimulation of facial, nasal or upper airway flow receptors may modulate 
the central perception of breathlessness and decrease neural respiratory drive.(16-18) Little or 
no effectiveness evidence exists for the CH and little is known about possible mechanisms for 
benefit, but is thought to target cognitive-emotional pathways to modulate the central 
perception of breathlessness. Both interventions are inexpensive, readily available, easy to 
use and portable providing the patient and carer with an intervention suited for self-
management strategies for exertion-induced breathlessness. 
We investigated the feasibility of conducting a phase III RCT to test the effectiveness of fan, 
CH or both compared with self-management and exercis  advice alone for the relief of 




The Calming Hand and Fan Feasibility (CHAFF) was a mixed method study: phase II, single 
site, “2x2” factorial, un-blinded randomised controlled trial and qualitative semi-structured 
interviews of participants and their carer’s. Potentially eligible participants were approached 
and screened by the patient’s usual clinician at an out-patient appointment at Castle Hill 
Hospital, Hull. Eligible patients were consenting adult respiratory outpatients with Medical 
Research Council (MRC) breathlessness scale grade ≥3 (19) due to an optimally treated 
respiratory disease. Patients were excluded if theyhad used the fan or CH within the previous 
two weeks, had trigeminal nerve damage or were too unwell to complete study procedures. 
Carers (if present) of the patient participants were also invited to consent to providing data 
about carer experience. Participants were allocated to xercise advice alone or with the 
addition of the fan, CH or both, according to a block randomisation schedule generated by a 
web-based random number sequence generator using a 1:1:1:1 ratio. This was managed by 
the Hull Clinical Trials Unit, who had access to sequ ntially numbered, opaque, sealed 
envelopes. The allocation was concealed from the study investigators although once 
randomised, blinding was not possible. Measures were taken at baseline and again at day 28. 
Fidelity of patient adherence was assessed by fan and/or CH use at day 28. Participants and 

















Participants were randomised after completion of all b seline measures. The intervention was 
delivered after randomisation during one visit to the Respiratory Clinical Trials Unit at Castle 
Hill Hospital, Hull. The intervention was provided by an academic physiotherapist 
researcher. All four groups received one-hour face-to-face individual training in standardised 
breathlessness self-management and exercise advice. All participants were given an 
information leaflet for use at home. This was adapted with permission from the Cambridge 
Breathlessness Intervention Service leaflets (20), available online and contained guidance on 
breathing control, recovery positions from breathlessness, activity pacing and exercise 
advice. 
Participants allocated to the CH and/or fan were instructed how to use the intervention(s) and 
encouraged to use whenever they felt breathless during the 28 day study period. A plastic, 3 
flexible blades, high flow fan was used. Their information sheets included instruction on how 
to use the CH and/or fan depending on allocation. Intervention components delivered were 
documented in the clinical record of each participant. 
Study Assessments and outcomes 
All study measures were assessed at baseline (day 0) and at 4 weeks (day 28) The same 
researcher who was not blinded to group assignment collected all of the outcome data and 
conducted the qualitative interviews at study end. 
At baseline clinical demographic data were collected about age, sex, diagnosis, oxygen 
therapy, mobility aids, carer status and the Charlson Co-morbidity Index.  
 
The feasibility outcomes were; 
• Recruitment rate, screening/consent ratio, randomisation and attrition  
• Data quality including patterns and proportions of missing data 
• Baseline variance of the candidate outcome measures to estimate sample size for a 
phase III trial: 
 
Exercise and activity 
Modified Incremental Shuttle Walk Test [mISWT] distance, a standardised incremental field 















mISWT followed standard procedures.(21) Life-space qu stionnaire, a measure of spatial 
mobility according to the level of movement a patient is able to make away from home with 
or without assistance and/or equipment.(23-25) 
Self-efficacy 
General Self-Efficacy Scale [GSES] (patient and carer), a 10 item 0-4 point scale (0 = not at 
all true, and 4 = exactly true) measure of a person’s beliefs about their capability to handle 
new or difficult tasks.(26, 27) 
 
Breathlessness assessment  
An 11 point numerical rating scale [NRS] 0-10 (0 = none, and 10 = worst possible) measure 
of breathlessness,(28) intensity on average and at its worst over the previous 24 hours, the 
unpleasantness of and distress due to breathlessness, and intensity at each time-point (every 
minute) during recovery time from maximal exertion-induced breathlessness from mISWT. 
Recovery time was defined as the time taken for the participant to return to their baseline 
NRS breathlessness intensity value from the point of maximal breathlessness after the ISWT. 
 
Carer assessment 
Zarit carer burden short-form, a 6 item 0-4 point scale (0 = never and, 4 = nearly always) 
measure of carer burden.(29, 30) 
 
Interviews 
Willing participants and carers were interviewed after study end (day 28). Participants were 
purposively sampled to include all participants from all four study arms and to gain 
maximum variation (age, sex, diagnosis, presence of arer). A topic guide was developed 
from the literature and research team experience to explore, i) the participant and carer 
experience of using the fan  and CH (or not) and the impact on the self-management of 
breathlessness, daily activities and exercise, and ii) the feasibility and acceptability of study 
participation including design and outcome measures. Interviews were conducted at the 
participant’s home individually and/or as a carer dyad. All interviews were audio-recorded 
and transcribed verbatim.  
 
The quantitative data are reported according to CONS RT guidelines (31) and the 
















Human Research Ethics approvals, including for the method of consent, and institutional 
permissions were obtained prior to recruitment (Leeds West Ethics committee, 12/YH/0410, 
12/09/2012). The study protocol was registered; ISRCTN40230190.  
 
Sample size 
It was considered that 40 participants was sufficient to address the feasibility questions and 




All randomly assigned participants were included in the Intention-to-Treat analysis. As a 
feasibility study the following descriptive analyses were conducted using SPSS (IBM Corp. 
Released 2013. IBM SPSS Statistics for Windows, Version 22.0. Armonk, NY: IBM Corp):  
• Descriptive analysis of recruitment  
• Descriptive analysis on the completion of endpoints 
• Calculation of the variance of change associated with the study outcome 
measurements. 
Findings were not adjusted for baseline values. Missing data were not imputed.  
 
Qualitative analysis.  
Qualitative interviews were imported into NVivo Version 7. Thematic analysis was used 
following a process of immersion in data, line-by-line coding, grouping of codes into initial 
themes, and then generation of major themes.(34) Four interview transcripts were 
independently coded by two researchers, Flavia Swan (FS) and Miriam Johnson (MJ). FS and 
MJ, then formulated a working coding framework. This was used by FS to systematically 
code, develop and organise the dataset into relevant categories with appropriate examples to 
illustrate the relevance to the research questions. 
 
Mixed-methods data synthesis 
A convergent design used concurrent quantitative and qualitative data collection followed by 
separate analyses of the data types, prior to integration and triangulation of the dataset at the 
















Participant characteristics  
Recruitment took place for 20 months during December 2012 and December 2014 
(researcher leave between September 2013 and Decembr 2013). 40 participants were 
randomised (mean age 72 years [SD 9.8], range 53-91; 28 [70%] male). Study flow can be 
seen in Figure 1. Baseline characteristics are summarised in Table 1. Of note breathlessness 
measures, particularly distress and worst intensity over the past 24 hours, were better in the 
groups allocated to CH. Most participants had idiopathic pulmonary fibrosis (IPF), 22 (55%) 
followed by chronic obstructive pulmonary disease (COPD) 12 (30%). All participants had 
co-morbid disease with three-quarters having a Charlson Co-morbidity index of ≤2. Baseline 
characteristics were generally balanced across the four arms, apart from participants with IPF, 
who were allocated to exercise advice 7 (70%), and exercise advice & CH 9 (90%). 
Interestingly, carers in the fan & CH group had less burden and better GSES.  
All participants received all components of the intervention. 
INSERT Table 1 
Feasibility outcomes 
The recruitment rate averaged 2.0/month. Of 53 participants screened, 13 (24%) were 
excluded; 2 (4%) were ineligible (1 cognitive impairment, 1 recent use of fan) and 11 (20%) 
declined to participate. Reasons for not participating were 1 (9%) carer duties, 1 (9%) 
hospitalisation, 4 (36.5%) other co-morbidity problems, 4 (36.5%) felt the study was too 
much and 1 (9%) no transport.  
Data completion 
40 participants were randomised and 40 completed th trial. All study measures were 
completed by all participants apart from 2 (5%) participants who did not take part in a 
mISWT on day 28. However, baseline mISWT data from 13 participants (33%) were 
excluded due to a protocol deviation (baseline mISWT and recovery time collected after 
delivery of intervention in error). 14 carers were recruited and 13 (92%) completed the study. 
Data were missing from one carer who was unable to attend the day 28 appointment. 
















Table 2 summarises the main outcomes for the 4 study arms at day 28 and the comparison of 
the mean change (day 28 minus baseline) and percentage between the groups for the potential 
phase III outcome measures. Recovery time after the mISWT and the mISWT distance were 
the only outcomes that signalled usefulness for a phase III trial. Recovery time (seconds) was 
fastest in the fan groups. Distress due to breathlessness improved by more in the CH groups.  
The mISWT distance (metres) increased in both groups allocated to the fan; mean changes 
from baseline were 55.33 (44%) fan & exercise advice and 31.86 (17%) fan & CH & exercise 
advice. In contrast, the CH & exercise advice group showed only slight improvement; 18.57 
(15%) and the walking distance decreased in the exercise advice group (-19.53, -11%).  
Improvements in carer outcomes were of note in the fan & CH & exercise advice arm only; 
mean change from baseline Zarit burden 1.75; (5%) and GSES 0.25; (7.1%). 
Overall, all 20 (100%) participants allocated to a fan arm were still using it on day 28, and 15 
(75%) said they used it every day. In contrast, although 18 (90%) of those allocated to a CH 
arm were still using it at day 28, only 8 (40%) said they used it every day. Of interest, those 
allocated to CH were more likely to use it every daif this was their sole intervention (CH 
only – 6 (60%) daily use vs CH and fan – 2 (20%) daily use) 
INSERT Table 2 
 
Semi-structured interviews 
A purposive sample of 11 participants and five carers took part in semi-structured interviews. 
All interviews apart from one patient/carer dyad were conducted individually at home. The 
four study arms were represented with at least two participants and one carer from each arm; 
seven participants and three carers had had experienc  of the fan, and six participants and two 
carers had had experience of the CH. Overall, participants found the fan acceptable partly 
because of ease of use, and partly because they perceived benefit. The CH was largely 

















Four key themes were generated from the data; 
1. The fan helps recovery from breathlessness 
Participants consistently suggested that one of the main benefits of using the fan was helping 
recovery from episodes of breathlessness. This influe ced how participants used the device as 
it was considered an extra tool that could easily be tailored to their daily breathlessness needs 
at any time or in any location. 
 
2. The fan supports exercise and activity 
 
This helped promote self-efficacy and participants felt more confident about self-managing 
their exertional breathlessness such that they wereable to continue or even try activity that 
they had not previously thought possible or had learn d to avoid.  
 
3. The fan was used like a medical device 
 
The value of the intervention was reflected in the way participants likened their use of the fan 
to a medical device, such as a replacement for a Ventolin inhaler or an adjunct between 
nebulisers. 
 
4. The CH was considered common sense and already known 
In contrast the CH was perceived as common sense and of little help managing 
breathlessness. Participants stated that the CH was a strategy that they had already tried in the 
past and as such it was nothing new. They described infrequent use to the extent of disregard. 
INSERT Table 3 
Discussion 
It is feasible to conduct a phase III RCT in terms of recruitment, data completion, and 
acceptability of study procedures and measures. However, the mixed-method data synthesis 
supports a future test of effectiveness of the fan, p rticularly during recovery from exertion-
induced breathlessness, but gives a less clear signal for the CH. Recovery time showed a 
quantitative signal of activity with the fan and was identified by participants as a particular 















was discernible as welcome by the patient; this benefit from the fan was seen as an important 
factor in breathlessness self-management,(36) and co tributed to its acceptability to the 
participants. Participants described how the fan enabled them to do more physical activity, 
sufficient to restore lost activities of daily living such as shopping or hobbies such as fishing.  
Quantitative data showed reduction in average daily distress due to breathlessness with the 
CH, but did not indicate benefit in either unpleasantness, intensity or worst distress in the past 
24 hours. Worst distress is likely to be related to exertion, and it may be that the CH is less 
useful in recovery where a fan is simpler to use under these circumstances. 
The recovery time data demonstrated a rapid return to baseline breathlessness score; all 
participants fully recovered from maximal exertional breathlessness in less than three minutes 
on average, and no longer than five, even after a walking test to maximal breathlessness. 
These figures are consistent with results from people with intra-thoracic cancer (median 4 
(IQR 2-5) minutes),(37) and indicate that patients with a diagnosis of COPD, IPF or asthma 
experience a similar rapid recovery from exertional breathlessness. This is clinically relevant 
important information to reassure patients that exertion-induced breathlessness usually 
recovers quickly countering beliefs that breathlessn  is harmful. 
Implications for clinical practice  
The fan is a valuable component of breathlessness management that is pragmatic and easy to-
administer. (15, 36, 38-40) Fear of breathlessness is a significant obstacle to exertion and 
exercise in people with chronic breathlessness and is a recognised factor in non-attendance of 
and drop-out from rehabilitation programmes.(12, 41) If the fan shortens recovery time and 
improves patient confidence, this may help reduce the vicious circle of deconditioning 
through exercise avoidance. It may also be useful to help adherence to pulmonary 
rehabilitation and long-term maintenance of outcomes.  
The other important potential for the fan is for use in breathlessness crisis; often exacerbated 
by anxiety and helplessness. “Fan to face” is already recommended as part of a breathlessness 
crisis plan.(42)  A third of patients with acute-onchronic breathlessness attending the 
emergency departments (ED) are discharged without need for hospital admission.(4) As 















and panic can be a greater risk,(7) the fan as a self-management strategy usable by patients 
and family carers may be of value to increase perceived control over breathlessness, 
particularly if used as a medical device. Indeed the qualitative findings suggest a useful role 
for the fan with “out of the blue” breathlessness (P18), a breathlessness category known to 
cause severe distress and initiate help-seeking.(7) 
Such self –efficacy is an important concept (43), and links to how effectively patients manage 
difficult symptoms with their quality of life.(44) Self-efficacy in coping with a breathlessness 
crisis is an important factor in avoiding ED presentation.(7) The patient’s experience of 
performance success or failure will likely validate or undermine their capabilities to cope 
with a given activity or situation. Significant improvements in the Chronic Respiratory 
Questionnaire’s breathlessness self-mastery domain were seen with a complex intervention 
for breathlessness management that included the fan.(45) Feasibility data has also indicated 
that the fan helps patients regain control and improve self-confidence to manage 
breathlessness by integrating into their daily activities and offering them a device that can be 
tailored to particular situations.(39)  
Implications for future research 
Although further value of information of a phase III trial of the fan as an isolated component 
for the benefit of breathlessness in everyday life is unlikely,(39), confirming its specific 
benefit on recovery time would be useful. If confirmed, this places the fan firmly as a tool to 
help improve daily physical activity, attendance and dherence to rehabilitation programmes, 
and as an adjunct to breathlessness crisis management.  
The lack of signal with CH may be because the trialw s not designed to discard the null 
hypothesis. However, given the strong comments from the qualitative study and the lack of 
other literature to support effectiveness, or to delineate possible mechanisms of action, these 
data do not support further study where recovery from exertion-induced breathlessness is the 
primary outcome. It may benefit distress due to breathl ssness in general and further work 

















The same person delivered the interventions and collected the outcome data, which could 
have added to the reporting bias resulting from the lack of blinding. In addition, as 
participants did not perform a training mISWT, any change in mISWT distance at day 28 
may represent learning.(22) However, i) these sources of bias will be consistent across all 
four study arms and, ii) the aim of this feasibility study was to inform the design of a phase 
III RCT, rather than evaluate effectiveness. The exclusion of 13 baseline mISWTs and 
breathlessness recovery measurements reduce the data anticipated for analysis. Therefore 
although the aim was to perform a sample size calculation this was deemed inappropriate as 
the estimate would have relied on too few data or wuld have involved combining data from 
two of the study arms; fan & exercise advice and fan & CH & exercise advice. Consequently 
further feasibility data is recommended to inform a ore precise estimate for a future test of 
the fan. 
The lack of IPF patients in either fan groups might be important if there is differential 
response to the fan or CH by diagnosis. However, the authors are unaware of any published 
observations with this regard.   
Our choice of a single face-to-face training session was made pragmatically aiming to 
minimise participant burden as our recruitment pathw y was likely to lead to a significant 
proportion of people with IPF. However, although their prognosis is similar to cancer, there 
are no data to confirm the effectiveness of a single session as there is for cancer.(46) This 
should be reviewed in the design on a subsequent trial. 
Finally, qualitative study is not designed to provide generalizable data. The semi-structured 
interview is inevitably influenced by the social interaction between the researcher and 
participant. Patients and carers may say what they think the researcher wanted to hear about 
the interventions in an attempt to please, although they did not seem to be constrained in 
reporting their adverse views about the CH. However, their views on cognitive interventions, 
rather than ones that can be more easily understood in a medical model (it was apparent that 
they viewed the fan in the same way as a medical device) may reflect regional and 
















A future phase III RCT to test the fan is feasible. Further feasibility data is recommended to 
accurately inform the sample size calculation. Mixed method data synthesis supports 
recovery time as a novel, meaningful outcome measur. The data do not support the use of 
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Table 1 Demographic Characteristics of study groups at baseline 
Demographic data Exercise advice 
(n=10) 
Fan & exercise 
advice (n=10) 
CH & exercise 
advice (n=10) 
Fan & CH & exercise 
advice (n=10) 
Total (n=40) 
Age:  70 (11.2), 53-86 70 (7.2), 61-84 79 (12.1), 59-91 71 (5.9), 56-71 72 (9.8), 53-91 













































NRS Intensity Average last 
24hrs  
5.0 (2.11) 2-8 5.5 (1.43) 4-8 4.7 (1.77) 2-8 4.8 (1.13) 3-7 5.0 (1.62) 2-8 
NRS Distress Average last 24hrs 4.8 (3.26) 0-9 5.6 ( 2.55) 0-9 3.7 (3.37) 0-9 3.3 (2.63) 0-8 4.3 (3.0) 0-9 
NRS Unpleasantness Average 
last 24hrs 
6.1 (2.68) 1-9 6.3 (2.16) 3-10 5.7 (2.26) 3-9 5.9 (2.18) 3-9 6.0 (2.25) 1-10 
NRS Intensity At worst last 24hrs 7.3 (1.7) 3-9 7.8 (1.32) 5-9 5.9 (2.28) 3-9 6.9 (1.66)  4-9 6.9 (1.85) 3-9 
NRS Distress At worst last 24hrs 6.1 (4.04) 0-10 7.0 (2.94) 0-10 4.1 (3.41) 0-9 4.3 (3.13) 0-9 5.3 (3.49) 0-10 






















Recovery time mISWT (seconds) 179.0 (69.14) 
98-303 MD = 3 
164.0 (70.18) 
90-291 MD = 4 
140.29 (36.75) 





mISWT distance (metres) 
 
192.86 (138.05) 
70-430 MD =3 
126.67 (81.65) 
30-210 MD =4 
121.43 (90.26) 
40-300 MD =3 
187.14 (85.97) 




Zarit carer burden  8.5 (4.95) 5-12 
(n=2) 
8 (3.56) 3-11 
(n=4) 
7.25 (4.19) 1-10 
(n=4) 




Carer GSES 33 (2.83) 31-35 
(n=2) 




35.0 (3.56) 31-38  (n=4) 33.57 (2.95) 
30-38 (n=14) 
Mean (SD) Range, MD = missing data; (n=) number of participants mISWT = modified incremental shuttle walk 

















Table 2 Patient and carer outcome measures day 28 mean change from baseline, absolute and percentage 
 Exercise advice (n=10)   Fan & Exercise advice (n=10)  CH & Exercise advice (n=10)   Fan & CH & Exercise advice (n=10) 
Patient Outcome 
measures 
















Average last 24hrs 
5.2 (1.99) 1-8                   
MD = 0 
0.2;  
4% 













Average last 24hrs 
5.2 (2.3), 2-8                    
MD = 0 
0.4;  
8.3% 




3.1 (2.02), 0-7                 
MD = 0 
-0.6;  
-16.2% 





Average last 24hrs 
5.9 (1.91), 3-9                  
MD = 0 
-0.2;  
-3.2% 




6.2 (2.20), 3-10               
MD = 0 
0.5;  
8.7% 




NRS Intensity At 
worst last 24 hours  
6.7 (1.34), 5-9                  
MD = 0 
-0.6;  
-8% 




6.8 (2.25), 3-10               
MD = 0 
0.9;  
15.2% 




NRS Distress At 
worst last 24 hours  
6.1 (2.47), 2-9                  
MD = 0 
0.0;  
No change 




4.1 (2.99), 0-9                 
MD = 0 
0.0;  
No change 






54.0 (24.21), 25-100        
MD = 0 
-0.45;  
-0.8% 




55.2 (14.67), 35-76         
MD = 0 
8.15;  
17.3% 
61.05 (27.06), 20-100          





32.0 (5.96), 20-40            
MD = 0 
1.7;  
5.6% 








32.4 (4.40), 22-40        





152.56 (41.45), 111-224  
MD = 1 
-26.44;  
-14.7% 








123.30 (24.93), 85-160 









182.0 (103.69), 50-340  
MD = 0 
55.33; 
43.7% 























Table 2 Patient and carer outcome measures day 28 mean change from baseline, absolute and percentage 
 Exercise advice  (n=2) Fan & Exercise advice (n=4) CH & Exercise advice (n=3) Fan & CH & Exercise advice (n=4) 
Carer Outcome 
measures 
Day 28 Mean Change; 
absolute, % 
Day 28 Mean Change; 
absolute, % 
Day 28 Mean Change; 
absolute, % 
Day 28 Mean 
Change; 
absolute,% 




8.75 (6.5), 0-15                
MD = 0 
0.75;  
9.3% 
5.00 (6.08),1-12   
MD = 1 
-2.25;  
-31% 
3.75 (2.63), 0-6      
MD = 0 
0.25;  
7.1% 
Carer GSES 32.5 (3.54), 30-35 
MD = 0 
̶0.5;  
1.5% 
31 (4.69), 25-36                
MD = 0 
-2.5;  
-7.5% 
32.67 (4.62), 30-38                    
MD = 1 
0.17;
0.5% 
36.75 (2.06), 35-39                  

















Table 3 Illustrative quotes 
 
Fan helps with recovery  
• P18: “I don’t know why I started cos I wasn’t exerting me-self as such I don’t know 
why I started sorta gasping and I thought right fanand after a few seconds back to 
normal” 
• P19: “I’ll just sit…put the fan six to eight inches away from me face on an angle so if 
I want it to go up me nose as well I can...I find coupla minutes it does take the 
breathlessness down.” 
• P24: “the recovery is quicker…it’s fifty percent I believe the air is being pushed in 
and fifty percent I’m confident as to what’s happening so I calm down quicker.”  
Fan supports activity and exercise 
• P9: “I can walk round when I take the fan…which I find very nice as I have never 
done it…this is a really big change…I can walk round [the shop]I can look at 
everything and I can read everything and it’s wonderful”  
• P11: “I’ve been going a bit further just recently since I’ve had me fan thing” 
• P19: Got me fan in me pocket and I’ve got me inhaler in me pocket so that I know if I 
ever go anywhere I’ve got more, more bases covered now I’ve got me fan as well” 
• P24 “So you’re hoping to go fishing again? A: “with me son next, next week, and it’ll 
be the first time in three years… and that’ll be [points to fan] going with me in me 
fishing bag” 
Fan is used like a medical device 
• P10: “I carry it around with me and I’ll use it you know because I feel a bit out of 
puff because it’s between nebulisers, I can’t take too many nebulisers so that acts as a 
prop in between.” 
• P12: “ I’ve been using the fan instead of Ventolin” 
• P17: “a little instrument or a tool you know…it’s a functional thing, it is a bit of 
equipment, not an idea yeah? You feel, once it’s switched on ….it is a physical thing , 
you can feel the effect of it” 
• P24: “Now I have the alternative, i.e. the fan, whereas I used to grab me inhaler and 
have two puffs, wait and hope something gets better; instead of that I get the fan…I’m 
not using my inhaler half as much as I did.” 
Calming Hand is common sense and things already known 
• P10: “What do you get with the Calming Hand?” A: “Nothing.” Q: Nothing? A: “No 
the Calming Hand are things I do myself any how if I feel very breathless… so that’s 
nothing really new.” 
• P15: “The Calming Hand…how did you find that?” A: “Well, common sense, its 
common sense.” 
• P17: “The Calming Hand, I didn’t think it was really of much value…I think I could 
find a lot of better ways of calming me-self down.” 
• P24: “I stopped doing the Calming Hand thing ‘cos t me I don’t need to do that to 


























Figure 1 CONSORT Flow-diagram (31) 
 
Assessed for eligibility (n=53) 
Excluded (n=13): 
Not meeting inclusion criteria (n= 2) 
Declined to participate (n= 11) 
Analysed (n=10) 
Excluded data 







Lost to follow-up 
(n=0) 
Discontinued fan & 
exercise advice 
(n=0) 






mISWT Day1 (n=4) 





Randomized (n= 40) 
Enrolment 
Allocated to fan & 
CH & exercise 
advice (n=10) 
Carers (n=4) 




Lost to follow-up 
(n=0) 
Discontinued fan & 




mISWT Day1 (n=3) 
& Day 28 (n=1) 
Carers (n= 4) 
Analysed (n=10) 
Excluded data 
mISWT Day1 (n=3) 
Carers (n=4) 
Lost to follow-up 
(n=0)  
Discontinued CH & 
exercise advice (n= 
0) 

















Online supplementary diagram  
Calming Hand 
 
 Using the Calming Hand 
1. Acceptance – Squeeze thumb and recognise that you are starting a 
breathless or panic attack. 
2. Sigh out. Flop and Drop – relax shoulders 
3. Breathe in and out slowly, gently and focus on the breath out. 
4. Stretch hands fully and then let them go 
You may need to repeat this several times before your breathing and anxiety start to 
